Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.19 USD
Change Today -0.62 / -1.27%
Volume 629.7K
ACAD On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael T. Borer

Independent Director and Member of Audit Committee, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
56$249,215

Background*

Mr. Michael T. Borer served as the Chief Executive Officer and President of Xcel Pharmaceuticals, Inc. from January 24, 2001 to 2005. Mr. Borer founded Xcel Pharmaceuticals, Inc. in 2001. Mr. Borer served as Senior Vice President and Chief Financial Officer of Dura Pharmaceuticals, Inc. from 1998 to 2001 and served in other management positions there from 1994 to 2000. Mr. Borer served as General Manager of Dura's Health Script division from 1996 to 1998. Mr. Borer joined ...

Read Full Background

Corporate Headquarters*

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

2005-Present
Independent Director and Member of Audit Committee

Education*

Bachelor's Degree
San Diego State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$44,000
Total Calculated Compensation$249,215
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $48.19 USD -0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.